Haoxi Health Technology Secures $12 Million in Public Offering

BEIJING, Sept. 20, 2024 - In a major boost for its operations, Haoxi Health Technology Limited, a prominent online marketing solutions provider based in Beijing, recently announced the successful closure of its underwritten follow-on public offering, garnering an impressive $12 million. This funding is expected to significantly contribute to the company’s expansion plans and further technological investments in the healthcare sector.

The company offered a total of 4,000,000 Units at a public price of $3.00 each, facilitating a procedure that witnessed a robust market response. Each Unit includes one Class A Ordinary Share (or a pre-funded warrant) and warrants that provide the option to purchase additional shares under certain conditions, giving investors multiple layers of engagement with the company’s growth trajectory.

Haoxi Health Technology’s recent offering opens new doors for growth and investment.

Detailed Breakdown of the Offering

The offering was meticulously structured, comprising each Unit containing one Class A Ordinary Share along with two types of warrants: a Series A warrant and a Series B warrant. The uniqueness of this package is self-evident; while the Series A warrant provides the right to purchase additional shares initially, the Series B warrant introduces a significant multi-fold increase in the number of shares purchasable, highlighting the company’s confidence in its future growth.

The established terms of the offering allow the firm to cover possible over-allotments—an option granted to underwriter EF Hutton LLC for additional purchase rights within a 45-day window post-closing—underscoring the deal’s attractive nature.

Company Leadership Speaks

Expressing optimism about the offering, Haoxi’s Chairman and CEO, Mr. Zhen Fan, shared his thoughts: > “We are pleased to close this offering and appreciate the continued support and market recognition as we execute our business plan. The proceeds provided by this offering will help facilitate our continued business expansion and technologies investment in healthcare industry.”

This sentiment resonates with investors hoping to see robust applications of the raised funds in innovative healthcare solutions, which are increasingly called for in today’s fast-evolving tech landscape.

Innovations in healthcare technology drive investment opportunities.

An Attractive Investment Landscape

The healthcare industry is currently poised for substantial growth driven by technological advancements, with many companies, including Haoxi, at the forefront. Investors are closely watching how these funds will be utilized effectively to penetrate deeper into the health tech market, aiming for a competitive edge.

Completed on a firm commitment basis, this strategic financing move signals Haoxi’s significant aspirations as it gears up for an ambitious phase of growth. By channeling these funds into innovative projects, the company is well-positioned in a sector that increasingly intertwines health and technology, promising not just returns but a lasting impact on healthcare accessibility and innovation.

Looking Ahead

As Haoxi continues to harness its resources and scale its operations, it remains committed to making notable advances in healthcare technology, setting a pioneering standard within the market. This underwritten public offering not only signifies strong investor confidence but also acts as a crucial enabler in propelling healthcare advancements that can benefit society at large.

It’s clear that with each step, Haoxi Health Technology is setting itself on a path of strategic growth, making them a company to watch in the upcoming years.